Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.

Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q30437993
Vorinostat in solid and hematologic malignanciesIcariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κBAntitumor activity of a novel antisense oligonucleotide against Akt1.Suberoylanilide hydroxamic acid induces apoptosis and sub-G1 arrest of 320 HSR colon cancer cells.Combination of sapacitabine and HDAC inhibitors stimulates cell death in AML and other tumour types.Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor.Epigenetics of lung cancer.The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancerHistone deacetylase inhibitors in lymphoma and solid malignancies.Targeting histone deacetylases for the treatment of diseaseHydroxamic acids (therapeutics and mechanism): chemistry, acyl nitroso, nitroxyl, reactive oxygen species, and cell signaling.Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline Moiety.Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells.Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells.Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates.Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.Histone deacetylase inhibitors in cancer therapy
P2860

Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.

Item
http://www.wikidata.org/entity/Q30437993
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Suberoylanilide hydroxamic aci ...... in non-small cell lung cancer.
@ast
Suberoylanilide hydroxamic aci ...... in non-small cell lung cancer.
@en
type
label
Suberoylanilide hydroxamic aci ...... in non-small cell lung cancer.
@ast
Suberoylanilide hydroxamic aci ...... in non-small cell lung cancer.
@en
prefLabel
Suberoylanilide hydroxamic aci ...... in non-small cell lung cancer.
@ast
Suberoylanilide hydroxamic aci ...... in non-small cell lung cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Suberoylanilide hydroxamic aci ...... in non-small cell lung cancer.
@en
P2093
P304
P31
P356
10.1016/J.SURG.2005.06.016
P407
P433
P478
P577
P698